JP2014501758A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501758A5
JP2014501758A5 JP2013546071A JP2013546071A JP2014501758A5 JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5 JP 2013546071 A JP2013546071 A JP 2013546071A JP 2013546071 A JP2013546071 A JP 2013546071A JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5
Authority
JP
Japan
Prior art keywords
protein
ligand
domain
domains
asparagine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013546071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501758A (ja
JP5974342B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2011/051536 external-priority patent/WO2012087230A1/en
Publication of JP2014501758A publication Critical patent/JP2014501758A/ja
Publication of JP2014501758A5 publication Critical patent/JP2014501758A5/ja
Application granted granted Critical
Publication of JP5974342B2 publication Critical patent/JP5974342B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013546071A 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス Active JP5974342B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061424725P 2010-12-20 2010-12-20
US61/424,725 2010-12-20
PCT/SE2011/051536 WO2012087230A1 (en) 2010-12-20 2011-12-19 Affinity chromatography matrix

Publications (3)

Publication Number Publication Date
JP2014501758A JP2014501758A (ja) 2014-01-23
JP2014501758A5 true JP2014501758A5 (enExample) 2015-02-05
JP5974342B2 JP5974342B2 (ja) 2016-08-23

Family

ID=46314245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546071A Active JP5974342B2 (ja) 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス

Country Status (5)

Country Link
US (1) US9683013B2 (enExample)
EP (1) EP2654915B1 (enExample)
JP (1) JP5974342B2 (enExample)
CN (1) CN103269761B (enExample)
WO (1) WO2012087230A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
SG186552A1 (en) 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
JPWO2013018880A1 (ja) * 2011-08-04 2015-03-05 独立行政法人産業技術総合研究所 プロテインgの細胞膜外ドメイン変異体のタンデム型多量体から成る新規な改変型タンパク質
US9657055B2 (en) * 2011-11-30 2017-05-23 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
US10189891B2 (en) * 2012-03-28 2019-01-29 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
MY178616A (en) 2012-09-17 2020-10-19 Grace W R & Co Chromatography media and devices
SG11201605712SA (en) 2014-01-16 2016-08-30 Grace W R & Co Affinity chromatography media and chromatography devices
CN104945488B (zh) * 2014-03-27 2020-02-18 迈格生物医药(上海)有限公司 一种具有免疫球蛋白结合能力的多肽
US11389783B2 (en) 2014-05-02 2022-07-19 W.R. Grace & Co.-Conn. Functionalized support material and methods of making and using functionalized support material
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN107108701B (zh) * 2014-12-17 2022-02-11 思拓凡生物工艺研发有限公司 修饰的κ轻链-结合多肽
KR102566292B1 (ko) 2015-06-05 2023-08-10 더블유.알. 그레이스 앤드 캄파니-콘. 흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법
GB201515339D0 (en) * 2015-08-28 2015-10-14 Ge Healthcare Bio Sciences Ab A seperation matrix and a method of seperating antibodies
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US11753438B2 (en) 2016-05-11 2023-09-12 Cytiva Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
CN109071613A (zh) 2016-05-11 2018-12-21 通用电气医疗集团生物工艺研发股份公司 分离基质
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
KR101857953B1 (ko) * 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
GB201615254D0 (en) 2016-09-08 2016-11-23 Ge Healthcare Bio Sciences Ab Novel Ligand and use thereof
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
WO2018151743A1 (en) 2017-02-15 2018-08-23 Bioprocessia Technologies Llc Affinity chromatography ligands with mild elution ph
GB201708277D0 (en) 2017-05-24 2017-07-05 Ge Healthcare A Recombinant protein
EP3875472A1 (en) * 2020-03-06 2021-09-08 Navigo Proteins Gmbh Novel immunoglobulin binding polypeptides
WO2022081779A1 (en) 2020-10-13 2022-04-21 Avitide LLC Affinity ligand libraries of three-helix bundle proteins and uses thereof
GB202018588D0 (en) 2020-11-26 2021-01-13 Cytiva Bioprocess R & D Ab Separation matrix
EP4294542A1 (en) 2021-02-19 2023-12-27 Avitide LLC Aav2 affinity agents
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US6602977B1 (en) 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
DK1641818T3 (da) * 2003-07-04 2009-03-16 Affibody Ab Polypeptider der har bindingsaffinitet for HER2
SE0400274D0 (sv) 2004-02-09 2004-02-09 Affibody Ab New polypeptide
ATE490268T1 (de) * 2005-03-01 2010-12-15 Affibody Ab Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
CN102989018A (zh) * 2005-08-03 2013-03-27 Rq生物科技有限公司 用于诊断IgA和IgM介导的肾脏疾病的方法和组合物
JP5229888B2 (ja) * 2008-09-30 2013-07-03 独立行政法人産業技術総合研究所 弱酸性域での易解離性を向上したプロテインa変異型タンパク質及び抗体捕捉剤
CN102272145B (zh) 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质

Similar Documents

Publication Publication Date Title
JP2014501758A5 (enExample)
JP2014500311A5 (enExample)
JP2012515160A5 (enExample)
JP2014502272A5 (enExample)
Gaberc‐Porekar et al. Potential for using histidine tags in purification of proteins at large scale
JP6856938B2 (ja) 新規な免疫グロブリン結合タンパク質およびアフィニティ精製におけるそれらの使用
Zhao et al. Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex
JP2007252368A5 (enExample)
JP2019531055A5 (enExample)
Zachariou et al. Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation
US20100069617A1 (en) Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
CN107001432A (zh) 突变的免疫球蛋白结合多肽
JP2019034963A (ja) 陽イオン交換基を用いた新規抗体精製法(Novel Antibody Purification method using Cation Exchanger)
CN103270044A (zh) 亲和色谱用载体和分离免疫球蛋白的方法
JP2016525100A5 (enExample)
EP4371996A3 (en) Methods for purifying antibodies
WO2011118599A1 (ja) アフィニティークロマトグラフィー用充填剤およびイムノグロブリンを単離する方法
Fan et al. Polydopamine meets porous membrane: a versatile platform for facile preparation of membrane adsorbers
Nian et al. Void exclusion of antibodies by grafted-ligand porous particle anion exchangers
RU2014118552A (ru) Способ выделения фукозилированных антител
CN104603153B (zh) 用于抗体纯化的载体、其制备方法及其应用
Scheffel et al. Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification
JP2015518489A5 (enExample)
JP2011001336A (ja) 新規なプロテインa固定化担体の製造方法
Opitz et al. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography